Dr Steven David, MD | |
1825 Route 23, Wayne, NJ 07470-7510 | |
(973) 633-1484 | |
(973) 633-7980 |
Full Name | Dr Steven David |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 38 Years |
Location | 1825 Route 23, Wayne, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902896723 | NPI | - | NPPES |
5232309 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 25MA05795000 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Chilton Medical Center | Pompton plains, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Gastroenterology Associates Of New Jersey Llc | 4284706656 | 65 |
News Archive
Janssen-Cilag Ltd today announced that NHS England will provide crucial funding for its once-daily, fixed-dose combination of darunavir and the pharmacoenhancer, cobicistat, called REZOLSTA.
A relatively common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer, and give cancer cells a growth advantage, according to a study in the October 5 issue of JAMA: The Journal of the American Medical Association.
Merck reported today that investigators in the TRA-2P study of vorapaxar have been provided with additional information about the recommendations of the Data and Safety Monitoring Board (DSMB) regarding the TRA-2P study. The additional information was sent yesterday in a communication to investigators from the Operations Committee of the TRA-2P study of vorapaxar. Vorapaxar is one of Merck's investigational cardiovascular medicines.
The Pennsylvania Department of Health recommends immunization of children and adults at the highest risk for hepatitis during "Hepatitis Awareness Month" and "World Hepatitis Day" on May 19.
› Verified 3 days ago
Entity Name | Gastroenterology Associates Of New Jersey Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497932271 PECOS PAC ID: 4284706656 Enrollment ID: O20081007000052 |
News Archive
Janssen-Cilag Ltd today announced that NHS England will provide crucial funding for its once-daily, fixed-dose combination of darunavir and the pharmacoenhancer, cobicistat, called REZOLSTA.
A relatively common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer, and give cancer cells a growth advantage, according to a study in the October 5 issue of JAMA: The Journal of the American Medical Association.
Merck reported today that investigators in the TRA-2P study of vorapaxar have been provided with additional information about the recommendations of the Data and Safety Monitoring Board (DSMB) regarding the TRA-2P study. The additional information was sent yesterday in a communication to investigators from the Operations Committee of the TRA-2P study of vorapaxar. Vorapaxar is one of Merck's investigational cardiovascular medicines.
The Pennsylvania Department of Health recommends immunization of children and adults at the highest risk for hepatitis during "Hepatitis Awareness Month" and "World Hepatitis Day" on May 19.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Steven David, MD 1130 Mcbride Ave Fl 3, Woodland Park, NJ 07424-3806 Ph: (973) 812-1400 | Dr Steven David, MD 1825 Route 23, Wayne, NJ 07470-7510 Ph: (973) 633-1484 |
News Archive
Janssen-Cilag Ltd today announced that NHS England will provide crucial funding for its once-daily, fixed-dose combination of darunavir and the pharmacoenhancer, cobicistat, called REZOLSTA.
A relatively common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer, and give cancer cells a growth advantage, according to a study in the October 5 issue of JAMA: The Journal of the American Medical Association.
Merck reported today that investigators in the TRA-2P study of vorapaxar have been provided with additional information about the recommendations of the Data and Safety Monitoring Board (DSMB) regarding the TRA-2P study. The additional information was sent yesterday in a communication to investigators from the Operations Committee of the TRA-2P study of vorapaxar. Vorapaxar is one of Merck's investigational cardiovascular medicines.
The Pennsylvania Department of Health recommends immunization of children and adults at the highest risk for hepatitis during "Hepatitis Awareness Month" and "World Hepatitis Day" on May 19.
› Verified 3 days ago
Dr. Philip John Filippis Ii, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 220 Hamburg Tpke, Suite 2, Wayne, NJ 07470 Phone: 973-389-9975 Fax: 973-389-9976 | |
Bassam Emile Hashem, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 224 Hamburg Tpke Ste 4023, Wayne, NJ 07470 Phone: 727-501-5729 Fax: 201-389-3619 | |
Anuradha R Konkesa, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 246 Hamburg Tpke Ste 207, Wayne, NJ 07470 Phone: 973-653-3366 Fax: 973-653-3365 | |
Dr. Barry Schair, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 246 Hamburg Tpke, Suite 201, Wayne, NJ 07470 Phone: 973-942-1141 Fax: 973-942-1250 | |
Dr. Michael Hubert Leonardo, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 510 Hamburg Tpke, Suite 101, Wayne, NJ 07470 Phone: 973-942-6005 Fax: 973-942-6009 | |
Dr. Bonnie Kingman Cheng, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1825 Route 23, Wayne, NJ 07470 Phone: 973-633-1484 Fax: 973-633-7980 | |
Dr. Sameer Anor Azhak, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 246 Hamburg Tpke, Suite 201, Wayne, NJ 07470 Phone: 973-942-1141 Fax: 973-942-1250 |